Cargando…
Neurodevelopmental outcomes at 7 years’ corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial
OBJECTIVE: To determine if improvements in cognitive outcome detected at 18 months’ corrected age (CA) in infants born <33 weeks’ gestation receiving a high-docosahexaenoic acid (DHA) compared with standard-DHA diet were sustained in early childhood. DESIGN: Follow-up of a multicentre randomised...
Autores principales: | Collins, Carmel T, Gibson, Robert A, Anderson, Peter J, McPhee, Andrew J, Sullivan, Thomas R, Gould, Jacqueline F, Ryan, Philip, Doyle, Lex W, Davis, Peter G, McMichael, Judy E, French, Noel P, Colditz, Paul B, Simmer, Karen, Morris, Scott A, Makrides, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368907/ https://www.ncbi.nlm.nih.gov/pubmed/25787990 http://dx.doi.org/10.1136/bmjopen-2014-007314 |
Ejemplares similares
-
Protocol for assessing whether cognition of preterm infants <29 weeks’ gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trial
por: Gould, Jacqueline F, et al.
Publicado: (2021) -
Protocol for assessing if behavioural functioning of infants born <29 weeks’ gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trial
por: Gould, Jacqueline F, et al.
Publicado: (2021) -
Protocol for a multicentre prospective observational study of families with full-term infants on postnatal wards and in the community to capture feeding practices across the first year of life: the Mother Infant Lactation Questionnaire (MILQ) study
por: Gould, Jacqueline F, et al.
Publicado: (2022) -
Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm
por: Sullivan, Thomas R., et al.
Publicado: (2023) -
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation
por: Collins, Carmel T., et al.
Publicado: (2016)